JP2005509634A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005509634A5 JP2005509634A5 JP2003537635A JP2003537635A JP2005509634A5 JP 2005509634 A5 JP2005509634 A5 JP 2005509634A5 JP 2003537635 A JP2003537635 A JP 2003537635A JP 2003537635 A JP2003537635 A JP 2003537635A JP 2005509634 A5 JP2005509634 A5 JP 2005509634A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- amino
- propanediol
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JQCIDLJJKVUJMC-QSWBWLQASA-N C[C@H](C[C@@H]1OC)[C@@](C(C(N(CCCC2)[C@@H]2C(O[C@@H]([C@H](C)[C@H](CC(C/C=C(\C)/C[C@H](C)C2)=O)O)/C(/C)=C/[C@H](CC[C@@H]3Cl)C[C@H]3OC)=O)=O)=O)(O)O[C@@H]1[C@H]2OC Chemical compound C[C@H](C[C@@H]1OC)[C@@](C(C(N(CCCC2)[C@@H]2C(O[C@@H]([C@H](C)[C@H](CC(C/C=C(\C)/C[C@H](C)C2)=O)O)/C(/C)=C/[C@H](CC[C@@H]3Cl)C[C@H]3OC)=O)=O)=O)(O)O[C@@H]1[C@H]2OC JQCIDLJJKVUJMC-QSWBWLQASA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0125443.2A GB0125443D0 (en) | 2001-10-23 | 2001-10-23 | Organic Compounds |
| GB0127341A GB0127341D0 (en) | 2001-11-14 | 2001-11-14 | Organic compounds |
| PCT/EP2002/011799 WO2003035068A1 (en) | 2001-10-23 | 2002-10-22 | Macrolides containing pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005509634A JP2005509634A (ja) | 2005-04-14 |
| JP2005509634A5 true JP2005509634A5 (enExample) | 2008-04-10 |
Family
ID=26246689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003537635A Pending JP2005509634A (ja) | 2001-10-23 | 2002-10-22 | マクロライドを含む医薬組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7259170B2 (enExample) |
| EP (1) | EP1439838A1 (enExample) |
| JP (1) | JP2005509634A (enExample) |
| KR (2) | KR20090114483A (enExample) |
| CN (1) | CN1307993C (enExample) |
| AU (1) | AU2002346859C1 (enExample) |
| BR (1) | BR0213463A (enExample) |
| CA (1) | CA2458690C (enExample) |
| EC (1) | ECSP045086A (enExample) |
| GB (1) | GB0125443D0 (enExample) |
| HU (1) | HUP0402108A3 (enExample) |
| IL (1) | IL160973A0 (enExample) |
| MX (1) | MXPA04003738A (enExample) |
| NO (1) | NO20042074L (enExample) |
| NZ (1) | NZ532412A (enExample) |
| PL (1) | PL368533A1 (enExample) |
| RU (1) | RU2321402C2 (enExample) |
| WO (1) | WO2003035068A1 (enExample) |
| ZA (1) | ZA200401711B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005512946A (ja) * | 2001-05-09 | 2005-05-12 | ノバルティス アクチエンゲゼルシャフト | 選択的免疫調節法 |
| RU2330839C2 (ru) | 2002-01-11 | 2008-08-10 | Санкио Компани, Лимитед | Производные аминоспиртов или производные фосфорных кислот и фармацевтические композиции, содержащие указанные производные |
| GB0307867D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Pharmaceutical composition |
| TWI355934B (en) | 2004-02-24 | 2012-01-11 | Sankyo Co | Pharmaceutical composition for treatment or prophy |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68921934T2 (de) | 1988-06-29 | 1995-10-19 | Merck & Co Inc | Immunsuppressives Agens. |
| US5352671A (en) * | 1989-11-09 | 1994-10-04 | Sandoz Ltd. | Heteroatoms-containing tricyclic compounds |
| DK0427680T3 (da) | 1989-11-09 | 1995-12-18 | Sandoz Ltd | Heteroatom-holdige cykliske forbindelser |
| GB2252041A (en) * | 1991-01-23 | 1992-07-29 | Fujisawa Pharmaceutical Co | Use of macrolide compounds in treatment of autoimmune myocarditis |
| WO1992016236A1 (en) * | 1991-03-19 | 1992-10-01 | Rajadhyaksha Vithal J | Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| US5247076A (en) * | 1991-09-09 | 1993-09-21 | Merck & Co., Inc. | Imidazolidyl macrolides having immunosuppressive activity |
| GB9203636D0 (en) * | 1992-02-19 | 1992-04-08 | Lucas Ind Plc | Fuel pumping apparatus |
| EP0627406B1 (en) * | 1992-10-21 | 1998-10-28 | Yoshitomi Pharmaceutical Industries, Ltd. | 2-amino-1,3-propanediol compound and immunosuppressant |
| CA2156065A1 (en) | 1993-03-17 | 1994-09-29 | Rolf Wagner | Macrocyclic amide and urea immunomodulators |
| US5590460A (en) * | 1994-07-19 | 1997-01-07 | Tessera, Inc. | Method of making multilayer circuit |
| JP3870419B2 (ja) * | 1994-08-22 | 2007-01-17 | 三菱ウェルファーマ株式会社 | ベンゼン化合物およびその医薬としての用途 |
| GB9521322D0 (en) | 1995-10-17 | 1995-12-20 | Sandoz Ltd | Organic compounds |
| JPH11209277A (ja) | 1998-01-19 | 1999-08-03 | Yoshitomi Pharmaceut Ind Ltd | 医薬組成物 |
| GB9624038D0 (en) | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| CA2286315C (en) * | 1997-04-04 | 2007-03-06 | Yoshitomi Pharmaceutical Industries Ltd. | 2-aminopropane-1,3-diol compound, pharmaceutical use thereof and synthetic intermediates therefor |
| GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
| JP4627356B2 (ja) * | 1999-06-30 | 2011-02-09 | 昭 松森 | ウイルス性心筋炎の予防または治療薬剤 |
| GB0003932D0 (en) | 2000-02-18 | 2000-04-12 | Novartis Ag | Pharmaceutical compositions |
| JP2004523275A (ja) | 2000-12-22 | 2004-08-05 | アバンテク バスキュラー コーポレーション | 治療能力のある薬剤の送達 |
-
2001
- 2001-10-23 GB GBGB0125443.2A patent/GB0125443D0/en not_active Ceased
-
2002
- 2002-10-22 CN CNB028211588A patent/CN1307993C/zh not_active Expired - Fee Related
- 2002-10-22 US US10/492,439 patent/US7259170B2/en not_active Expired - Fee Related
- 2002-10-22 PL PL02368533A patent/PL368533A1/xx not_active Application Discontinuation
- 2002-10-22 WO PCT/EP2002/011799 patent/WO2003035068A1/en not_active Ceased
- 2002-10-22 KR KR1020097021354A patent/KR20090114483A/ko not_active Ceased
- 2002-10-22 BR BR0213463-2A patent/BR0213463A/pt not_active IP Right Cessation
- 2002-10-22 EP EP02782975A patent/EP1439838A1/en not_active Withdrawn
- 2002-10-22 IL IL16097302A patent/IL160973A0/xx unknown
- 2002-10-22 HU HU0402108A patent/HUP0402108A3/hu unknown
- 2002-10-22 MX MXPA04003738A patent/MXPA04003738A/es active IP Right Grant
- 2002-10-22 KR KR1020047005958A patent/KR100978971B1/ko not_active Expired - Fee Related
- 2002-10-22 AU AU2002346859A patent/AU2002346859C1/en not_active Ceased
- 2002-10-22 RU RU2004116067/15A patent/RU2321402C2/ru not_active IP Right Cessation
- 2002-10-22 NZ NZ532412A patent/NZ532412A/en unknown
- 2002-10-22 CA CA2458690A patent/CA2458690C/en not_active Expired - Fee Related
- 2002-10-22 JP JP2003537635A patent/JP2005509634A/ja active Pending
-
2004
- 2004-03-02 ZA ZA200401711A patent/ZA200401711B/en unknown
- 2004-04-23 EC EC2004005086A patent/ECSP045086A/es unknown
- 2004-05-19 NO NO20042074A patent/NO20042074L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2521672T3 (es) | Formulaciones farmacéuticas para el tratamiento del cáncer | |
| JP2005506352A5 (enExample) | ||
| RU2007105568A (ru) | Эффективный способ использования лекарственных средств и способ предотвращения выраженности побочных эффектов | |
| JP2004531517A5 (enExample) | ||
| JP2008514732A5 (enExample) | ||
| JP2008521827A5 (enExample) | ||
| RU99112577A (ru) | Новое применение 1,3-пропандиольных производных | |
| US20080015261A1 (en) | Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function | |
| ES2356986T3 (es) | Agentes antitumorales. | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
| RU2005131845A (ru) | Способ лечения легкого ухудшения познавательной способности и предотвращения или задержки начала болезни альцгеймера | |
| JP2002539089A5 (enExample) | ||
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| RU2006138495A (ru) | Использование агонистов рецепторов, активируемых пролифератором пероксисомы дельта для лечения рс и других демиелинизирующих заболеваний | |
| JP2023502053A5 (enExample) | ||
| JPH1036365A5 (enExample) | ||
| RU2002102076A (ru) | Фармацевтическая композиция, содержащая сибутрамин и орлистат | |
| JP2002522462A5 (enExample) | ||
| JP2003534318A5 (enExample) | ||
| CN1870989A (zh) | 用于治疗眼科疾病的香豆素衍生物 | |
| JP2003534317A5 (enExample) | ||
| JP2021529189A5 (enExample) | ||
| RU2009149637A (ru) | Композиции, применимые для лечения гастроэзофагеальной рефлюксной болезни | |
| CA2468811A1 (en) | Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders |